<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">1782737</PMID>
      <DateCompleted>
        <Year>1992</Year>
        <Month>03</Month>
        <Day>19</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2018</Year>
        <Month>11</Month>
        <Day>13</Day>
      </DateRevised>
      <Article PubModel="Print">
        <Journal>
          <ISSN IssnType="Print">0312-5963</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>21</Volume>
            <Issue>6</Issue>
            <PubDate>
              <Year>1991</Year>
              <Month>Dec</Month>
            </PubDate>
          </JournalIssue>
          <Title>Clinical pharmacokinetics</Title>
          <ISOAbbreviation>Clin Pharmacokinet</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Felodipine clinical pharmacokinetics.</ArticleTitle>
        <Pagination>
          <StartPage>418</StartPage>
          <EndPage>430</EndPage>
          <MedlinePgn>418-30</MedlinePgn>
        </Pagination>
        <Abstract>
          <AbstractText>Absorption of felodipine is rapid and complete. A pronounced first-pass metabolism results in a bioavailability of 15%, irrespective of the oral formulation used. The peak plasma concentrations and area under the plasma concentration-time curve are linearly related to the dose. The variability in plasma concentrations is wide, and individualization of the dosage is recommended. Plasma felodipine concentrations are increased in the elderly, and in patients with congestive heart failure or liver cirrhosis; in these patients felodipine should be started at a low dosage. Food intake has no clinically significant effect on felodipine absorption. Serum digoxin concentrations are increased by felodipine in plain tablet form, but not when it is administered as extended release tablets. Activators, inducers and inhibitors of the cytochrome P450 system affect the plasma concentrations of felodipine. No displacement reactions with high affinity protein binding drugs have been observed. There is a significant correlation between plasma concentration and haemodynamic effect. The mean elimination half-life of 24h together with the extended release formulation of felodipine favours once-daily dosage in patients with hypertension.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Dunselman</LastName>
            <ForeName>P H</ForeName>
            <Initials>PH</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Cardiology, Ignatius Hospital, Breda, The Netherlands.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Edgar</LastName>
            <ForeName>B</ForeName>
            <Initials>B</Initials>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
      </Article>
      <MedlineJournalInfo>
        <Country>Switzerland</Country>
        <MedlineTA>Clin Pharmacokinet</MedlineTA>
        <NlmUniqueID>7606849</NlmUniqueID>
        <ISSNLinking>0312-5963</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>OL961R6O2C</RegistryNumber>
          <NameOfSubstance UI="D015736">Felodipine</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D001682" MajorTopicYN="N">Biological Availability</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004347" MajorTopicYN="N">Drug Interactions</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005243" MajorTopicYN="N">Feces</DescriptorName>
          <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015736" MajorTopicYN="N">Felodipine</DescriptorName>
          <QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName>
          <QualifierName UI="Q000493" MajorTopicYN="Y">pharmacokinetics</QualifierName>
          <QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
          <QualifierName UI="Q000652" MajorTopicYN="N">urine</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007408" MajorTopicYN="N">Intestinal Absorption</DescriptorName>
          <QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015394" MajorTopicYN="N">Molecular Structure</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D012016" MajorTopicYN="N">Reference Values</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <NumberOfReferences>82</NumberOfReferences>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="pubmed">
          <Year>1991</Year>
          <Month>12</Month>
          <Day>1</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>1991</Year>
          <Month>12</Month>
          <Day>1</Day>
          <Hour>0</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>1991</Year>
          <Month>12</Month>
          <Day>1</Day>
          <Hour>0</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">1782737</ArticleId>
        <ArticleId IdType="doi">10.2165/00003088-199121060-00003</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Eur J Clin Pharmacol. 1983;24(1):49-53</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6832201</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Br Heart J. 1984 Oct;52(4):431-4</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6477781</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Drugs. 1985;29 Suppl 2:87</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3987556</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Cardiovasc Pharmacol. 1989 Sep;14(3):438-43</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2476624</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Pharmacol Ther. 1985 Aug;38(2):205-11</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">4017422</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Chromatogr. 1990 Jun 29;528(2):343-56</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2384574</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Drugs. 1985;29 Suppl 2:176-84</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3987546</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Br Heart J. 1987 Nov;58(5):505-11</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3314956</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Drugs. 1987;34 Suppl 3:125-31</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3443058</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lancet. 1991 Feb 2;337(8736):268-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1671113</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eur J Clin Pharmacol. 1989;36(5):473-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2753065</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Drugs. 1985;29 Suppl 2:46-58</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3987552</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eur J Clin Pharmacol. 1985;28(5):489-93</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3899668</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Br J Clin Pharmacol. 1989 Jul;28(1):45-52</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2673315</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Cardiovasc Pharmacol. 1988 Aug;12(2):134-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2459543</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Br J Clin Pharmacol. 1986 Jun;21(6):633-40</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3527242</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Br Heart J. 1984 Sep;52(3):314-20</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6466518</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Cardiovasc Pharmacol. 1990 Dec;16(6):910-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1704983</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Pharmacokinet. 1988 Aug;15(2):94-113</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3064953</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eur J Clin Pharmacol. 1986;30(2):133-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3519241</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hypertension. 1986 Dec;8(12):1172-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3539796</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Cardiovasc Pharmacol. 1990 Mar;15(3):428-35</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">1691367</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eur J Clin Pharmacol. 1987;31(5):575-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3830242</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Naunyn Schmiedebergs Arch Pharmacol. 1983 Aug;323(4):350-4</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6633675</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Br J Clin Pharmacol. 1991 Jan;31(1):15-24</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2015166</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Br J Clin Pharmacol. 1990 Jan;29(1):39-45</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2404502</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Drugs. 1987;34 Suppl 3:16-27</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3327676</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Drugs. 1985;29 Suppl 2:9-15</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3987557</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Drugs. 1987;34 Suppl 3:33-42</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3443063</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Invest Med. 1987 Sep;10(5):388-94</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3677507</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eur J Clin Pharmacol. 1988;35(5):461-5</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3069476</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Br Heart J. 1984 Apr;51(4):445-51</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6704264</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xenobiotica. 1984 Sep;14(9):719-26</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6516445</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Cardiovasc Pharmacol. 1987;10 Suppl 1:S177-84</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2442513</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cancer Res. 1981 Jan;41(1):67-72</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">7448777</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Br Heart J. 1987 Aug;58(2):122-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3304372</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eur Heart J. 1989 Apr;10(4):354-64</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2656266</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Br J Clin Pharmacol. 1989 Jan;27(1):67-74</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2706189</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Drugs. 1985;29 Suppl 2:109-16</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2859183</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eur Heart J. 1986 Jan;7(1):54-60</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3956523</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Intern Med. 1989 Apr;225(4):237-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2656902</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Br J Clin Pharmacol. 1988 Nov;26(5):535-45</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2905154</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Pharmacol Ther. 1990 Sep;48(3):309-17</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2401128</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Pharmacol Exp Ther. 1989 Aug;250(2):632-6</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2760845</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Biopharm Drug Dispos. 1987 May-Jun;8(3):235-48</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3593901</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Drugs. 1987;34 Suppl 3:43-52</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3443064</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Pharmacokinet. 1988 Jun;14(6):374-83</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3396260</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lancet. 1988 Aug 27;2(8609):480-2</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2900404</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Drugs. 1988 Oct;36(4):387-428</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3069435</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Biochem Pharmacol. 1986 May 1;35(9):1419-25</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3011017</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eur J Clin Pharmacol. 1989;37(5):459-65</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2598984</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Cardiovasc Pharmacol. 1985 May-Jun;7(3):544-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2410688</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Clin Pharmacol. 1990 Nov;30(11):1020-30</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">2243149</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Pharm Biomed Anal. 1984;2(3-4):519-26</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">16867732</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clin Pharmacol Ther. 1986 Aug;40(2):239-42</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">3731687</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>J Pharmacol Exp Ther. 1984 Feb;228(2):420-4</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">6694119</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
